SLS
SELLAS Life Sciences Group, Inc.
$12.76
-0.75 (-5.55%)
At close · Jul 10
Market Cap
$2.37B
Shares
186,032,574
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-25 | 2026-06-24 | |
| 8-K | 2026-06-18 | 2026-06-16 | |
| 8-K | 2026-06-02 | — | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-23 | 2026-06-16 | |
| 8-K | 2026-03-19 | — | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-11 | — | |
| 8-K | 2026-01-08 | 2026-01-07 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-10-27 | 2025-10-24 | |
| 8-K | 2025-10-03 | 2025-10-01 | |
| 8-K | 2025-09-11 | 2025-09-10 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-18 | 2025-06-17 | |
| 8-K | 2025-06-06 | 2025-06-03 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-23 | 2025-06-17 | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-01-29 | 2025-01-28 | |
| 8-K | 2025-01-23 | — | |
| 8-K | 2025-01-16 | 2025-01-10 | |
| 8-K | 2024-12-10 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-10-04 | 2024-10-03 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-01 | 2024-07-30 | |
| 8-K | 2024-06-21 | 2024-06-20 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-20 | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2024-03-28 | — | |
| 8-K | 2024-03-28 | — | |
| 8-K | 2024-03-15 | — | |
| 8-K | 2024-03-11 | — | |
| 8-K | 2024-03-08 | 2024-03-06 | |
| 8-K | 2024-03-05 | — | |
| 8-K | 2024-02-16 | 2024-02-14 | |
| 8-K | 2024-01-08 | 2024-01-04 | |
| 8-K | 2024-01-03 | 2024-01-02 | |
| 8-K | 2023-12-22 | 2023-12-19 | |
| 8-K | 2023-12-13 | 2023-12-11 |
Showing 1–50 of 121 filings